10.1371/journal.pone.0139377.t005
Tian-Xiao Li
Tian-Xiao
Li
Bu-Lang Gao
Bu-Lang
Gao
Dong-Yang Cai
Dong-Yang
Cai
Zi-Liang Wang
Zi-Liang
Wang
Liang-Fu Zhu
Liang-Fu
Zhu
Jiang-Yu Xue
Jiang-Yu
Xue
Wei-Xing Bai
Wei-Xing
Bai
Ying-Kun He
Ying-Kun
He
Li Li
Li
Li
Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.
Public Library of Science
2015
intracranial atherosclerotic stenosis
lt
ias
stroke rate
hemorrhagic stroke rate
intracranial Wingspan stenting
Single Medical Center PurposeTo
433 Patients Treated
basilar artery area
perioperative stroke rate
MethodsBetween July 2007
2015-09-30 03:08:16
Dataset
https://plos.figshare.com/articles/dataset/_Disabling_or_fatal_stroke_rate_within_and_beyond_30_days_in_the_SAMMPRIS_study_/1560373
<p>Note:</p><p><sup>#</sup> The disabling or fatal stroke rates within 30 days could be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.t003" target="_blank">Table 3</a> in reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref008" target="_blank">8</a>.</p><p>* The disabling or fatal stroke rates at the end of 32.4 months of follow-up for both groups could be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.t003" target="_blank">Table 3</a> in reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref009" target="_blank">9</a>.</p><p>** The number of patients with disabling or fatal stroke beyond 30 days was 21–16 = 5 for the PTAS group but 18–4 = 14 for the MED group, whereas the number of patients who finished the follow-up was 191 for the PTAS group and 210 for the MED group (see the Results of reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0139377#pone.0139377.ref009" target="_blank">9</a>). PTAS: percutaneous transluminal angioplasty and stenting; MED: medical management group.</p><p>Disabling or fatal stroke rate within and beyond 30 days in the SAMMPRIS study.</p>